New study tests Stoma-Free option for rectal cancer patients

NCT ID NCT07605611

Recruiting now Disease control Sponsor: Tongji Hospital Source: ClinicalTrials.gov ↗

First seen Jun 27, 2026 · Last updated Jun 27, 2026

Summary

This study looks at whether giving a drug called somatostatin along with a clear liquid diet for a week after rectal cancer surgery can prevent dangerous bowel leaks as well as a temporary stoma (a bag outside the body). About 72 adults with low or mid rectal cancer will be randomly assigned to one of these two approaches. The goal is to see if the drug-and-diet method can reduce the need for a stoma while keeping patients safe.

This is an AI summary of the original study and may miss details. Read our disclaimer.

Get updates

Get notified about this study

Sign up to get updates when this study changes or when new studies for ANASTOMOTIC LEAKAGE are added.

Our safety recommendation!

By submitting, you agree to our Terms of use

Conditions

The condition(s) this trial relates to.

Anastomotic Leak rectal cancer rectal neoplasm

As listed by the trial registrant

The condition terms exactly as the trial's registrant entered them.

ANASTOMOTIC LEAKAGE RECTAL CANCER

Contacts and locations

Locations

Ezhou Central Hospital
RECRUITING

Ezhou, Hubei, China
Tongji Hospital, Tongji Medical College, Huazhong University of Science and Technology
RECRUITING

Wuhan, Hubei, China
Wuhan No. 6 Hospital
NOT_YET_RECRUITING

Wuhan, Hubei, China

More trials for these conditions

Other studies related to the condition(s) this trial covers.